Hefen Sun
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Oncology 19
- Cancer Cells and Metastasis 7
- HER2/EGFR in Cancer Research 4
- Co-authors
- Wei Jin (29 shared papers)Liangdong Li (15 shared papers)Shuiping Gao (12 shared papers)Yang Zhao (14 shared papers)Wenyan Fu (7 shared papers)Honglin Jiang (4 shared papers)Chao Ge (5 shared papers)Jinjun Li (5 shared papers)
- Journals
- Oncotarget (4 papers)Cancer Medicine (4 papers)Theranostics (2 papers)Annals of Oncology (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Hefen Sun
43 papers receiving 983 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 341
- Oncology 329
- Molecular Biology 585
- Pulmonary and Respiratory Medicine 157
- Cell Biology 77
Countries citing papers authored by Hefen Sun
This map shows the geographic impact of Hefen Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hefen Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hefen Sun more than expected).
Fields of papers citing papers by Hefen Sun
This network shows the impact of papers produced by Hefen Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hefen Sun. The network helps show where Hefen Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Hefen Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 133 | |
| 2 | 2012 | 82 | |
| 3 | 2015 | 58 | |
| 4 | 2013 | 56 | |
| 5 | 2012 | 50 | |
| 6 | 2012 | 43 | |
| 7 | 2018 | 42 | |
| 8 | 2015 | 40 | |
| 9 | 2022 | 38 | |
| 10 | 2015 | 32 | |
| 11 | 2021 | 29 | |
| 12 | 2019 | 28 | |
| 13 | 2019 | 26 | |
| 14 | 2013 | 25 | |
| 15 | 2018 | 25 | |
| 16 | UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter. | 2017 | 24 |
| 17 | 2018 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 2015 | 20 | |
| 20 | 2021 | 20 |
About Hefen Sun
Hefen Sun is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 44 papers that have together received 995 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Breast Cancer Treatment Studies (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), HER2/EGFR in Cancer Research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (341 citations), Oncology (329 citations), Molecular Biology (585 citations), Pulmonary and Respiratory Medicine (157 citations) and Cell Biology (77 citations). Hefen Sun has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Wei Jin, Liangdong Li, Shuiping Gao, Yang Zhao, Wenyan Fu, Honglin Jiang, Chao Ge, Jinjun Li, Lipeng Yang and Mengting Chen. Their work appears in journals such as Oncotarget, Cancer Medicine, Theranostics, Annals of Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.